Liver Disease Diagnostics Market - By End Consumption (Hospitals, Laboratories, Biopsy), By Diagnosis Techniques (Imaging, Laboratory Tests, Endoscopy, Biopsy) And By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, Opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 189
Status: Published
Report Code: ARI100761
For instance, according to the WHO, in 2020, 841,080 new cases of liver cancer were reported globally and an estimated 781, 631 people died due to liver cancer. Rising initiatives undertaken by key players to develop highly sensitive and rapid tests to detect liver diseases in specific populations such as pregnant women and HIV-positive patients is anticipated to boost the market for liver disease diagnostics. For instance, in February 2020, Abbott received a CE mark for Determine HBsAg 2 test, a sensitive, easy-to-use, and rapid diagnostic test used for the detection of hepatitis B. Furthermore, increasing R&D of accurate diagnostic systems to improve early diagnosis and patient outcomes is expected to propel the growth of the market for liver disease diagnostics. In March 2020, F. Hoffmann-La Roche Ltd. was granted Breakthrough Device Designation for Elecsys GALAD score. Elecsys GALAD score was developed under Roche Diagnostics Liver Indication Program to improve diagnostic workflow and support clinicians by providing accurate information.
The presence of favourable reimbursement policies by Medicare, Medicaid, and other health insurance programs is expected to accelerate the market for liver disease diagnostics. The Medicare coverage policy in Code Map, a leading source of reimbursement solutions, and Medicare compliance includes piccolo express liver panel plus developed by Abbott with a Medicare reimbursement of USD 30.89.
In addition, the introduction of novel methods to diagnose diseases is likely to have a positive impact on the market for liver disease diagnostics. For instance, in December 2017, VITROS ALTV Slides, a new and novel method for the measurement of Alanine Aminotransferase (ALT) using dry slide technology was developed by Ortho Clinical Diagnostics. This novel method reduces the volume of sample requirement, increases sensitivity, and enhances precision performance.
Key market players in global liver disease diagnostics market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, Siemens AG (Siemens Healthineers), Bayer AG, Merck & Co., Inc., Sanofi S.A., Novartis AG, Pfizer, Inc., and Randox laboratories limited.
Analyst Commentary
With increasing prevalence of liver diseases, increasing awareness has become a necessity. Government and not-for-profit organizations are playing a crucial role in the rising awareness about the liver diseases around the world. These organizations promote the awareness of the liver related diseases and support for research and development for the prevention, treatment and cure of liver diseases.
The imaging segment dominated the market and held a revenue share in 2020. This is attributed to the rising number of initiatives taken by key players in the market for liver disease diagnostics to develop advanced imaging techniques. Laboratory tests are carried out using urine, blood, and other fluid samples to diagnose the liver function. Whereas, imaging includes ultrasound, X-ray, Magnetic Resonance Imaging (MRI) scan, Computed Tomography (CT) scan, and Biopsy. Imaging is estimated to witness a significant CAGR during the forecast period.
In addition, the key players in the market for liver disease diagnostics are undertaking initiatives to support non-profit organizations to raise awareness and help physicians in detecting liver diseases. In January 2020, Echosens supported Fatty Liver Foundation (FLF) by providing FibroScan to help clinicians in detecting, monitoring, and preventing liver diseases.
Segmentation
The global liver disease diagnostics market is segmented based on end consumption, diagnosis techniques and geography. On the basis of diagnosis techniques, the market is bifurcated into Imaging, Laboratory tests, Endoscopy, Biopsy. On the basis of End consumption, the market is segmented into Hospitals, Laboratories, Biopsy.
The hospitals segment held the largest revenue share in 2020 as the majority of patients rely on hospitals well-equipped with diagnostic testing devices. Hospitals provide optimal care to patients and enable early detection & diagnosis, thus boosting the growth of the market for liver disease diagnostics. Furthermore, the on-going development of healthcare infrastructure is anticipated to enhance the existing hospital facilities.
The laboratories segment is projected to be the fastest growing segment in the liver disease diagnostics market over the forecast years. Various laboratories and institutes conduct awareness programs to diagnose hepatic organ disease. For instance, in December 2017, the Institute of Liver and Biliary Sciences collaborated with Mylan Laboratories to conduct screening and awareness programs. The aim was to provide quality screening and testing facilities for more than 1000 patients in Delhi. The program conducted tests such as Hepatitis B & C, Fibroscan, and ALT.
Regional Analysis
North America dominated the market and held a revenue share in 2020, followed by Europe. High investments in R&D and presence of key players are some factors expected to be responsible for the growth of the market for liver disease diagnostics in the region. Furthermore, the presence of organizations that provide information regarding the diagnosis of diseases to patients is expected to fuel the growth of the market for liver disease diagnostics. One such organization is GetPalliativeCare.org that provides palliative care information related to diagnostic methods such as endoscopy, CT scan, and biopsy.
The market for liver disease diagnostics in the Asia Pacific is expected to grow at a significant rate during the forecast period. Increasing geriatric population and awareness about regular check-ups are contributing to the growth of the market for liver disease diagnostics in this region. Furthermore, regulatory approval of advanced technologies that can be integrated with imaging systems is estimated to drive regional growth. For instance, in August 2020, LiverMultiScan received clearance from Therapeutic Goods Administration (TGA) to diagnose patients with highly prevalent diseases in Australia such as NAFLD and NASH.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Component
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Liver Disease Diagnostics Market
Chapter 5. Global Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027(USD Billion)
5.1. Global Liver Disease Diagnostics Market Share, By End Consumption, 2015 - 2027 (USD Billion)
5.1.1. Hospitals
5.1.1.1. Market Size and Projections,2015 - 2027 (USD Billion)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.2. Laboratories
5.1.2.1. Market Size and Projections,2015 - 2027 (USD Billion)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.3. Others
5.1.3.1. Market Size and Projections,2015 - 2027 (USD Billion)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 6. Global Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027(USD Billion)
6.1. Global Liver Disease Diagnostics Market Share, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
6.1.1. Imaging
6.1.1.1. Market Size and Projections,2015 - 2027 (USD Billion)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.2. Laboratory tests
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.3. Endoscopy
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.4. Biopsy
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.5. Others
6.1.5.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.5.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 7. Global Liver Disease Diagnostics Market Overview, By Geography, 2015 - 2027(USD Billion)
7.1. Global Liver Disease Diagnostics Market Share, By Geography, 2015 - 2027(USD Billion)
7.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Billion)
7.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 8. North America Liver Disease Diagnostics Market Overview, By Countries, 2015 - 2027(USD Billion)
8.1. North America Liver Disease Diagnostics Market Overview, 2015 - 2027 (USD Billion)
8.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
8.1.2. North America Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027 (USD Billion)
8.1.3. North America Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
8.1.4. North America Liver Disease Diagnostics Market Overview, By Countries, 2015 - 2027 (USD Billion)
8.1.4.1. U.S. Liver Disease Diagnostics Market Overview, 2015 - 2027 (USD Billion)
8.1.4.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
8.1.4.1.2. U.S. Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027 (USD Billion)
8.1.4.1.3. U.S. Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
8.1.4.2. Canada Liver Disease Diagnostics Market Overview, 2015 - 2027 (USD Billion)
8.1.4.2.1. Market Size and projections, 2015 - 2027 (USD Billion)
8.1.4.2.2. Canada Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027 (USD Billion)
8.1.4.2.3. Canada Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
8.1.4.3. Mexico Liver Disease Diagnostics Market Overview, 2015 - 2027 (USD Billion)
8.1.4.3.1. Market Size and projections, 2015 - 2027 (USD Billion)
8.1.4.3.2. Mexico Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027 (USD Billion)
8.1.4.3.3. Mexico Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
Chapter 9. Europe Liver Disease Diagnostics Market Overview, By Countries, 2015 - 2027(USD Billion)
9.1. Europe Liver Disease Diagnostics Market Overview, 2015 - 2027 (USD Billion)
9.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
9.1.2. Europe Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027 (USD Billion)
9.1.3. Europe Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
9.1.4. Europe Skin Care Sizes Market Overview, By Countries, 2015 - 2027 (USD Billion)
9.1.4.1. Germany
9.1.4.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
9.1.4.1.2. Germany Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027(USD Billion)
9.1.4.1.3. Germany Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027(USD Billion)
9.1.4.2. France
9.1.4.2.1. Market Size and projections, 2015 - 2027 (USD Billion)
9.1.4.2.2. France Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027(USD Billion)
9.1.4.2.3. France Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027(USD Billion)
9.1.4.3. UK
9.1.4.3.1. Market Size and projections, 2015 - 2027 (USD Billion)
9.1.4.3.2. UK Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027(USD Billion)
9.1.4.3.3. UK Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027(USD Billion)
9.1.4.4. Italy
9.1.4.4.1. Market Size and projections, 2015 - 2027 (USD Billion)
9.1.4.4.2. Italy Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027(USD Billion)
9.1.4.4.3. Italy Liver Disease Diagnostics Market Overview, By Diagnostic Techniques 2015 - 2027(USD Billion)
9.1.4.5. Spain
9.1.4.5.1. Market Size and projections, 2015 - 2027 (USD Billion)
9.1.4.5.2. Spain Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027(USD Billion)
9.1.4.5.3. Spain Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027(USD Billion)
9.1.4.6. Rest of Europe
9.1.4.6.1. Market Size and projections, 2015 – 2027
9.1.4.6.2. Rest of Europe Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027(USD Billion)
9.1.4.6.3. Rest of Europe Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027(USD Billion)
Chapter 10. Asia Pacific Liver Disease Diagnostics Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1. Asia Pacific Liver Disease Diagnostics Market Overview, 2015 - 2027 (USD Billion)
10.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
10.1.2. Asia Pacific Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027 (USD Billion)
10.1.3. Asia Pacific Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
10.1.4. Asia Pacific Liver Disease Diagnostics Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1.4.1. India
10.1.4.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
10.1.4.1.2. India Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027(USD Billion)
10.1.4.1.3. India Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
10.1.4.2. China
10.1.4.2.1. Market Size and projections, 2015 - 2027(USD Billion)
10.1.4.2.2. China Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027(USD Billion)
10.1.4.2.3. China Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
10.1.4.3. Japan
10.1.4.3.1. Market Size and projections, 2015 - 2027 (USD Billion)
10.1.4.3.2. Japan Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027(USD Billion)
10.1.4.3.3. Japan Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027(USD Billion)
10.1.4.4. South Korea
10.1.4.4.1. Market Size and projections, 2015 - 2027(USD Billion)
10.1.4.4.2. South Korea Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027(USD Billion)
10.1.4.4.3. South Korea Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
10.1.4.5. Rest of Asia Pacific
10.1.4.5.1. Market Size and projections, 2015 - 2027 (USD Billion)
10.1.4.5.2. Rest of Asia Pacific Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027(USD Billion)
10.1.4.5.3. Rest of Asia Pacific Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
Chapter 11. Middle East & Africa Liver Disease Diagnostics Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1. Middle East & Africa Liver Disease Diagnostics Market Overview, 2015 - 2027 (USD Billion)
11.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
11.1.2. Middle East & Africa Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027 (USD Billion)
11.1.3. Middle East & Africa Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
11.1.4. Middle East & Africa Liver Disease Diagnostics Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1.4.1. GCC
11.1.4.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
11.1.4.1.2. GCC Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027 (USD Billion)
11.1.4.1.3. GCC Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
11.1.4.2. South Africa
11.1.4.2.1. Market Size and projections, 2015 - 2027 (USD Billion)
11.1.4.2.2. South Africa Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027 (USD Billion)
11.1.4.2.3. South Africa Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
11.1.4.3. Rest of Middle East & Africa
11.1.4.3.1. Market Size and projections, 2015 - 2027 (USD Billion)
11.1.4.3.2. Rest of Middle East & Africa Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027 (USD Billion)
11.1.4.3.3. Rest of Middle East & Africa Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
Chapter 12. South America Liver Disease Diagnostics Market Overview, By Countries, 2015 - 2027 (USD Billion)
12.1. South America Liver Disease Diagnostics Market Overview, 2015 - 2027 (USD Billion)
12.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
12.1.2. South America Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027 (USD Billion)
12.1.3. South America Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
12.1.4. South America Liver Disease Diagnostics Market Overview, By Countries, 2015- 2026 (USD Billion)
12.1.5. Brazil
12.1.5.1. Market Size and projections, 2015 - 2027 (USD Billion)
12.1.5.2. Brazil Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027 (USD Billion)
12.1.5.3. Brazil Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
12.1.6. Argentina
12.1.6.1. Market Size and projections, 2015 - 2027 (USD Billion)
12.1.6.2. Argentina Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027 (USD Billion)
12.1.6.3. Argentina Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
12.1.7. Rest of South America
12.1.7.1. Market Size and projections, 2015 – 2027
12.1.7.2. Rest of South America Liver Disease Diagnostics Market Overview, By End Consumption, 2015 - 2027 (USD Billion)
12.1.7.3. Rest of South America Liver Disease Diagnostics Market Overview, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
Chapter 13. Competitive Landscape
13.1. Competitive environment, 2020
13.2. Strategic framework
13.2.1. Partnership/agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New Size development
Chapter 14. Key Vendor Analysis
14.1. Abott laboratories
14.1.1. Company overview
14.1.2. Financial performance
14.1.3. Product Benchmarking
14.1.4. Recent initiatives
14.1.5. SWOT analysis
14.2. F. Hoffmann-La Roche AG
14.2.1. Company overview
14.2.2. Financial performance
14.2.3. Product Benchmarking
14.2.4. Recent initiatives
14.2.5. SWOT analysis
14.3. Boston Scientific Corporation
14.3.1. Company overview
14.3.2. Financial performance
14.3.3. Product Benchmarking
14.3.4. Recent initiatives
14.4. Siemens AG
14.5. Others
Chapter 15. Liver Disease Diagnostics Market Cost Analysis
15.1. Liver Disease Diagnostics Market Key Size Analysis
15.1.1. Key Size
15.1.2. Price Trend of Key Size
15.1.3. Key Suppliers of Size
15.1.4. Market Concentration Rate of Size
15.1.5. Labor Cost
Chapter 16. Sourcing Strategy and Downstream Buyers
16.1. Liver Disease Diagnostics Market Chain Analysis
16.2. Upstream Size Sourcing
16.3. Liver Disease Diagnostics Market Major Manufacturers in 2021
16.4. Downstream Buyers
Chapter 17. Marketing Strategy Analysis, Distributors/Traders
17.1. Marketing Channel
17.1.1. Direct Marketing
17.1.2. Indirect Marketing
17.1.3. Marketing Channel Development Trend
17.2. Market Positioning
17.2.1. Pricing Strategy
17.2.2. Brand Strategy
17.2.3. Target Client
17.3. Distributors/Traders List
Chapter 18. Market Effect Factors Analysis
18.1. Technology Progress/Risk
18.1.1. Substitutes Threat
18.1.2. Technology Progress in Related Size
18.2. Consumer Needs/Customer Preference Change
18.3. Economic/Political Environmental Change
Chapter 19. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Liver Disease Diagnostics Market share, By End Consumption, 2020 & 2027 (%)
10. Global Liver Disease Diagnostics Market share, by Hospitals, By End Consumption, 2015 - 2027 (USD Billion)
11. Global Liver Disease Diagnostics Market share, by Laboratories, By End Consumption, 2015 - 2027 (USD Billion)
12. Global Liver Disease Diagnostics Market share, by Others, By End Consumption, 2015 - 2027 (USD Billion)
13. Global Liver Disease Diagnostics Market share, By Diagnostic Techniques, 2020 & 2027 (%)
14. Global Liver Disease Diagnostics Market share, by Imaging, By Diagnostic Techniques, 2015 - 2027 (USD Billion)
15. Global Liver Disease Diagnostics Market share, by Laboratory tests, By Diagnostic Techniques 2015 - 2027 (USD Billion)
16. Global Liver Disease Diagnostics Market share, by Endoscopy, By Diagnostic Techniques 2015 - 2027 (USD Billion)
17. Global Liver Disease Diagnostics Market share, by Biopsy, By Diagnostic Techniques 2015 - 2027 (USD Billion)
18. Global Liver Disease Diagnostics Market share, by Others, By Diagnostic Techniques 2015 - 2027 (USD Billion)
19. Global Liver Disease Diagnostics Market share, by region, 2020 & 2027 (%)
20. Global Liver Disease Diagnostics Market share, by region, 2015 - 2027(USD Billion)
21. North America Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
22. North America Liver Disease Diagnostics Market share, by Countries, 2020 & 2027 (%)
23. U.S. Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
24. Canada Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
25. Mexico Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
26. Europe Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
27. Europe Liver Disease Diagnostics Market share, by Countries, 2020 & 2027 (%)
28. Spain Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
29. UK Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
30. Italy Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
31. Germany Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
32. France Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
33. Rest of Europe Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
34. Asia-Pacific Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
35. Asia-Pacific Liver Disease Diagnostics Market share, by Countries, 2020 & 2027 (%)
36. China Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
37. India Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
38. Australia Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
39. Japan Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
40. Rest of Asia-Pacific Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
41. Middle East & Africa Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
42. Middle East & Africa Liver Disease Diagnostics Market share, by Countries, 2020 & 2027 (%)
43. GCC Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
44. South Africa Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
45. Rest Of Middle East & Africa Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
46. South America Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
47. Brazil Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
48. Mexico Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
49. Argentina Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
50. Rest Of South America Liver Disease Diagnostics Market, 2015 - 2027(USD Billion)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Liver Disease Diagnostics Market, 2015-2027 (USD Billion)
4. Liver Disease Diagnostics requirement, by country, 2015-2027, (USD Billion)
5. North America Liver Disease Diagnostics Market, By End Consumption, 2015-2027 (USD Billion)
6. North America Liver Disease Diagnostics Market, By Diagnostic Techniques, 2015-2027 (USD Billion)
7. Europe Liver Disease Diagnostics Market, By End Consumption, 2015-2027 (USD Billion)
8. Europe Liver Disease Diagnostics Market, By Diagnostic Techniques, 2015-2027 (USD Billion)
9. Asia Pacific Liver Disease Diagnostics Market, By End Consumption, 2015-2027 (USD Billion)
10. Asia Pacific Liver Disease Diagnostics Market, By Diagnostic Techniques, 2015-2027 (USD Billion)
11. Middle East & Africa Liver Disease Diagnostics Market, By End Consumption, 2015-2027 (USD Billion)
12. Middle East & Africa Liver Disease Diagnostics Market, By Diagnostic Techniques, 2015-2027 (USD Billion)
13. South America Liver Disease Diagnostics Market, By End Consumption, 2015-2027 (USD Billion)
14. South America Liver Disease Diagnostics Market, By Diagnostic Techniques, 2015-2027 (USD Billion)
15. Global Liver Disease Diagnostics Market, Company Market Share, 2020 - 2027 (%)
16. Abott laboratories: Product Benchmarking
17. Abott laboratories: Financial Performance
18. F. Hoffmann-La Roche AG: Product Benchmarking
19. F. Hoffmann-La Roche AG: Financial Performance
20. Boston Scientific Corporation.: Product Benchmarking
21. Boston Scientific Corporation.: Financial Performance
22. Siemens AG: Product Benchmarking
23. Siemens AG: Financial Performance
The Leading Key Players in Liver Disease Diagnostics Market
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Boston Scientific Corporation
Siemens AG (Siemens Healthineers)
Bayer AG
Merck & Co. Inc.
Sanofi S.A.
Novartis AG
Pfizer Inc.
Randox laboratories limited
